The findings, presented at the European Respiratory Society (ERS) International Congress 2020, show better moderate-or-severe and severe exacerbation rates in patients whose asthma is uncontrolled on ...

Patients with type 2-high asthma who were being treated with high-dose inhaled corticosteroids (ICS) had reduced exacerbations and improved lung function when they were switched to dupilumab.

Of the 1,505 patients in the LIBERTY ASTHMA QUEST study, 282 had fungal sensitization at baseline; of those, 155 were on high-dose ICS (placebo, 63; dupilumab, 92) and 127 were on medium-dose ICS ...

When compared to high-dose ICS treatment paired with a placebo, the monoclonal antibody with medium-dose ICS treatment reduced severe asthma exacerbations by 70% (0.273 vs 0.899 per year, P<0.0001 ...

High-dose, once-daily Enerzair® Breezhaler® [IND/GLY/MF] reduced asthma exacerbation rates by 21% (moderate or severe) and 31% (severe) versus medium-dose, over 52 weeks1 Once-daily Enerzair ...

Maintenance of asthma was defined as no asthma exacerbations since the previous visit, no increase in Asthma Control Questionnaire (ACQ-5), and no significant increase in ICS-formoterol reliever ...

Novartis announced that high-dose, once-daily Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone furoate [IND/GLY/MF]) significantly reduces both moderate-or-severe and ...

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database of Systematic Reviews , 2010 (10): CD007524 DOI: 10.1002 ...

LOUISVILLE, Ky. — Patients with asthma faced high risks for exacerbations despite their maintenance medication or disease severity, reported researchers at the American College of Allergy ...

October 7, 2010 — Increasing the inhaled corticosteroid (ICS) dose when an asthma exacerbation begins may not reduce the need for rescue oral corticosteroids, according to the results of a ...

There is no evidence that increasing the dose of inhaled corticosteroids at the onset of an asthma exacerbation, as part of a patient-initiated action plan, reduces the need for rescue oral ...

TUESDAY, Oct. 29, 2024 (HealthDay News) -- For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist ...